Basic & Clinical Pharmacology 13th Edition

Book Preface

The thirteenth edition of Basic & Clinical Pharmacology continues the important changes inaugurated in the eleventh edition, with extensive use of full-color illustrations and expanded coverage of transporters, pharmacogenomics, and new drugs. Case studies accompany most chapters and answers to questions posed in the case studies appear at the end of each chapter. As in prior editions, the book is designed to provide a comprehensive, authoritative, and readable pharmacology textbook for students in the health sciences. Frequent revision is necessary to keep pace with the rapid changes in pharmacology and therapeutics; the 2–3 year revision cycle of the printed text is among the shortest in the field and the availability of an online version provides even greater currency. The book also offers special features that make it a useful reference for house officers and practicing clinicians.

Information is organized according to the sequence used in many pharmacology courses and in integrated curricula: basic principles; autonomic drugs; cardiovascular-renal drugs; drugs with important actions on smooth muscle; central nervous system drugs; drugs used to treat inflammation, gout, and diseases of the blood; endocrine drugs; chemotherapeutic drugs; toxicology; and special topics. This sequence builds new information on a foundation of information already assimilated. For example, early presentation of autonomic nervous system pharmacology allows students to integrate the physiology and neuroscience they have learned elsewhere with the pharmacology they are learning and prepares them to understand the autonomic effects of other drugs. This is especially important for the cardiovascular and central nervous system drug groups. However, chapters can be used equally well in courses and curricula that present these topics in a different sequence.

Within each chapter, emphasis is placed on discussion of drug groups and prototypes rather than offering repetitive detail about individual drugs. Selection of the subject matter and the order of its presentation are based on the accumulated experience of teaching this material to thousands of medical, pharmacy, dental, podiatry, nursing, and other health science students.

Major features that make this book particularly useful in integrated curricula include sections that specifically address the clinical choice and use of drugs in patients and the monitoring of their effects—in other words, clinical pharmacology is an integral part of this text. Lists of the trade and generic names of commercial preparations available are provided at the end of each chapter for easy reference by the house officer or practitioner writing a chart order or prescription.
Significant revisions in this edition include:

• Addition of a chapter on pharmacogenomics, an area of increasing importance in all aspects of pharmacology. The drug development and regulation material previously covered in Chapter 5 has been incorporated into Chapter 1.
• A generic name–trade name table appears at the conclusion of most chapters, providing a rapid reference for these names.
• Many revised illustrations in full color provide significantly more information about drug mechanisms and effects and help to clarify important concepts.
• Major revisions of the chapters on sympathomimetic, diuretic, antipsychotic, antidepressant, antidiabetic, anti-inflammatory, and antiviral drugs, prostaglandins, nitric oxide, hypothalamic and pituitary hormones, central nervous system neurotransmitters, immunopharmacology, and toxicology.
• Continued expansion of the coverage of general concepts relating to newly discovered receptors, receptor mechanisms, and drug transporters.
• Descriptions of important new drugs released through August 2014.
An important related educational resource is Katzung & Trevor’s Pharmacology: Examination & Board Review , tenth edition

(Trevor AJ, Katzung BG, & Masters SB: McGraw-Hill, 2013). This book provides a succinct review of pharmacology with approximately one thousand sample examination questions and answers. It is especially helpful to students preparing for board-type examinations. A more highly condensed source of information suitable for review purposes is USMLE Road Map: Pharmacology, second edition (Katzung BG, Trevor AJ: McGraw-Hill, 2006).
This edition marks the 32th year of publication of Basic & Clinical Pharmacology. The widespread adoption of the first twelve editions indicates that this book fills an important need. We believe that the thirteenth edition will satisfy this need even more successfully. Spanish, Portuguese, Italian, French, Indonesian, Japanese, Korean, Turkish, and Ukrainian translations are available. Translations into other languages are under way; the publisher may be contacted for further information.

I wish to acknowledge the prior and continuing efforts of my contributing authors and the major contributions of the staff at Lange Medical Publications, Appleton & Lange, and McGraw-Hill, and of our editors for this edition, Donna Frassetto and Rachel D’Annucci Henriquez. I also wish to thank Alice Camp and Katharine Katzung for their expert proofreading contributions.

Suggestions and comments about Basic & Clinical Pharmacology are always welcome. They may be sent to me in care of the publisher.

Bertram G. Katzung, MD, PhD San Francisco
December, 2011

Contents
Preface
Authors
SECTION I BASIC PRINCIPLES
1. Introduction: The Nature of Drugs & Drug Development & Regulation Bertram G. Katzung, MD, PhD
2. Drug Receptors & Pharmacodynamics Mark von Zastrow, MD, PhD
3. Pharmacokinetics & Pharmacodynamics: Rational Dosing & the Time Course of Drug Action Nicholas H. G. Holford, MB, ChB, FRACP
4. Drug Biotransformation Maria Almira Correia, PhD
5. Pharmacogenomics Jennifer E. Hibma, PharmD, & Kathleen M. Giacomini, PhD
SECTION II AUTONOMIC DRUGS
6. Introduction to Autonomic Pharmacology Bertram G. Katzung, MD, PhD
7. Cholinoceptor-Activating & Cholinesterase-Inhibiting Drugs Achilles J. Pappano, PhD
8. Cholinoceptor-Blocking Drugs Achilles J. Pappano, PhD
9. Adrenoceptor Agonists & Sympathomimetic Drugs Italo Biaggioni, MD, & David Robertson, MD
10. Adrenoceptor Antagonist Drugs David Robertson, MD, & Italo Biaggioni, MD
SECTION III CARDIOVASCULAR-RENAL DRUGS
11. Antihypertensive Agents Neal L. Benowitz, MD
12. Vasodilators & the Treatment of Angina Pectoris Bertram G. Katzung, MD, PhD
13. Drugs Used in Heart Failure Bertram G. Katzung, MD, PhD
14. Agents Used in Cardiac Arrhythmias Joseph r. Hume, PhD, & Augustus O. Grant, MD, PhD
15. Diuretic Agents Ramin Sam, MD, David Pearce, MD, & Harlan E. Ives, MD, PhD
SECTION IV DRUGS WITH IMPORTANT ACTIONS ON SMOOTH MUSCLE
16. Histamine, Serotonin, & the Ergot Alkaloids Bertram G. Katzung, MD, PhD
17. Vasoactive Peptides Ian A. Reid, PhD
18. The Eicosanoids: Prostaglandins, Thromboxanes, Leukotrienes, & Related Compounds Emer M. Smyth, PhD, & Garret A. FitzGerald, MD
19. Nitric Oxide Samie R. Jaffrey, MD, PhD
20. Drugs Used in Asthma Joshua M. Galanter, MD, & Homer A. Boushey, MD
SECTION V DRUGS THAT ACT IN THE CENTRAL NERVOUS SYSTEM
21. Introduction to the Pharmacology of CNS Drugs John A. Gray, MD, PhD, & Roger A. Nicoll, MD
22. Sedative-Hypnotic Drugs Anthony J. Trevor, PhD
23. The Alcohols Susan B. Masters, PhD, & Anthony J. Trevor, PhD
24. Antiseizure Drugs Roger J. Porter, MD, & Brian s. Meldrum, MB, PhD
25. General Anesthetics Helge Eilers, MD, & Spencer Yost, MD
26. Local Anesthetics Kenneth Drasner, MD
27. Skeletal Muscle Relaxants Marieke Kruidering-Hall, PhD, & Lundy Campbell, MD
28. Pharmacologic Management of Parkinsonism & Other Movement Disorders Michael J. Aminoff, MD, DSc, FRCP
29. Antipsychotic Agents & Lithium Charles DeBattista, MD
30. Antidepressant Agents Charles DeBattista, MD
31. Opioid Agonists & Antagonists Mark A. Schumacher, PhD, MD, Allan I. Basbaum, PhD, & Ramana K. Naidu, MD
32. Drugs of Abuse Christian Lüscher, MD
SECTION VI DRUGS USED TO TREAT DISEASES OF THE BLOOD, INFLAMMATION, & GOUT
33. Agents Used in Cytopenias; Hematopoietic Growth Factors James L. Zehnder, MD
34. Drugs Used in Disorders of Coagulation James L. Zehnder, MD
35. Agents Used in Dyslipidemia Mary J. Malloy, MD, & John P. Kane, MD, PhD
36. Nonsteroidal Anti-Inflammatory Drugs, Disease-Modifying Antirheumatic Drugs, Nonopioid Analgesics, & Drugs Used in Gout Nabeel H. Borazan, MD, & Daniel E. Furst, MD
SECTION VII ENDOCRINE DRUGS
37. Hypothalamic & Pituitary Hormones Roger K. Long, MD, & Hakan Cakmak, MD
38. Thyroid & Antithyroid Drugs Betty J. Dong, PharmD, FASHP, FCCP, & Francis S. Greenspan, MD, FACP
39. Adrenocorticosteroids & Adrenocortical Antagonists George P. Chrousos, MD
40. The Gonadal Hormones & Inhibitors George P. Chrousos, MD
41. Pancreatic Hormones & Antidiabetic Drugs Martha S. Nolte Kennedy, MD, & Umesh Masharani, MBBS, MRCP (UK)
42. Agents That Affect Bone Mineral Homeostasis Daniel D. Bikle, MD, PhD
SECTION VIII CHEMOTHERAPEUTIC DRUGS
43. Beta-Lactam & Other Cell Wall- & Membrane-Active Antibiotics Daniel H. Deck, PharmD, & Lisa G. Winston, MD
44. Tetracyclines, Macrolides, Clindamycin, Chloramphenicol, Streptogramins, & Oxazolidinones Daniel H. Deck, PharmD, & Lisa G. Winston, MD
45. Aminoglycosides & Spectinomycin Daniel H. Deck, PharmD, & Lisa G. Winston, MD
46. Sulfonamides, Trimethoprim, & Quinolones Daniel H. Deck, PharmD, & Lisa G. Winston, MD
47. Antimycobacterial Drugs Daniel H. Deck, PharmD, & Lisa G. Winston, MD
48. Antifungal Agents Don Sheppard, MD, & Harry W. Lampiris, MD
49. Antiviral Agents Sharon Safrin, MD
50. Miscellaneous Antimicrobial Agents; Disinfectants, Antiseptics, & Sterilants Daniel H. Deck, PharmD, & Lisa G. Winston, MD
51. Clinical Use of Antimicrobial Agents Harry W. Lampiris, MD, & Daniel S. Maddix, PharmD
52. Antiprotozoal Drugs Philip J. Rosenthal, MD
53. Clinical Pharmacology of the Antihelminthic Drugs Philip J. Rosenthal, MD
54. Cancer Chemotherapy Edward Chu, MD, & Alan C. Sartorelli, PhD
55. Immunopharmacology Douglas F. Lake, PhD, & Adrienne D. Briggs, MD
SECTION IX TOXICOLOGY
56. Introduction to Toxicology: Occupational & Environmental Daniel T. Teitelbaum, MD
57. Heavy Metal Intoxication & Chelators Michael J. Kosnett, MD, MPH
58. Management of the Poisoned Patient Kent R. Olson, MD
SECTION X SPECIAL TOPICS
59. Special Aspects of Perinatal & Pediatric Pharmacology Gideon Koren, MD
60. Special Aspects of Geriatric Pharmacology Bertram G. Katzung, MD, PhD
61. Dermatologic Pharmacology Dirk B. Robertson, MD & Howard I. Maibach, MD
62. Drugs Used in the Treatment of Gastrointestinal Diseases Kenneth R. McQuaid, MD
63. Therapeutic & Toxic Potential of Over-the-Counter Agents Robin L. Corelli, PharmD
64. Dietary Supplements & Herbal Medications Cathi E. Dennehy, PharmD, & Candy Tsourounis, PharmD
65. Rational Prescribing & Prescription Writing Paul W. Lofholm, PharmD, & Bertram G. Katzung, MD, PhD
66. Important Drug Interactions & Their Mechanisms John R. Horn, PharmD, FCCP
Appendix: Vaccines, Immune Globulins, & Other Complex Biologic Products Harry W. Lampiris, MD, & Daniel S. Maddix, PharmD
Index